@article{97358d0f4c374315b87b03be500c8aad,
title = "Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment",
keywords = "Adolescent, Child, Child, Preschool, Chromosome Breakpoints, Cohort Studies, DNA-Binding Proteins/genetics, Enzyme Inhibitors/pharmacology, Female, Histone-Lysine N-Methyltransferase, Humans, Infant, Male, Myeloid-Lymphoid Leukemia Protein/genetics, Nuclear Proteins/genetics, Oncogene Proteins, Fusion/genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics, Pregnancy, Prenatal Exposure Delayed Effects, Recombination, Genetic, Survival Rate, Topoisomerase II Inhibitors, Transcriptional Elongation Factors",
author = "R Jung and U Jacobs and M Krumbholz and T Langer and T Keller and \{De Lorenzo\}, P and Valsecchi, \{M G\} and \{van der Velden\}, \{V H J\} and A Moericke and M Stanulla and A Teigler-Schlegel and Panzer-Gruemayer, \{E R\} and \{van Dongen\}, \{J J M\} and M Schrappe and \{den Boer\}, \{M L\} and R Pieters and W Rascher and M Metzler",
note = "Funding Information: We thank all members of the participating INTERFANT-99 study groups for providing patients samples and clinical data. This study was supported by a Wilhelm–Sander Foundation grant to MM and TL. RJ was supported by a grant from the Carreras Foundation. ERP-G was supported by GENAU-CHILD Project GZ200.136/1FVI/1/2005 and the St Anna Kinderkrebsforschung. Funding Information: We wish to thank Mrs Dominique Bouchot, Martine Courtois, Isabelle Helot and Aur{\'e}lie Herry (CHU Dijon), for excellent technical help, and Philip Bastable for revisions. This work was supported by a grant from the Ligue contre le Cancer, Comit{\'e} de C{\^o}te d{\textquoteright}Or.",
year = "2010",
month = apr,
doi = "10.1038/leu.2010.14",
language = "English",
volume = "24",
pages = "903--7",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "4",
}